Collectively, our clinical and mechanistic evidence strongly suggested that dysregulated Ezh2 expression mediating abnormal Akt/PTEN signaling critically contributes to GC pathogenesis and aggressive behavior. This evidence concerns the gene EZH2 and gastric cancer.